ARTICLE | Clinical News
SyStemix preclinical data
June 5, 1995 7:00 AM UTC
SyStemix Inc. (STMX), Palo Alto Product: Hematopoietic stem cell transplants Indication: Support multiple myeloma patients undergoing chemotherapy Status: Began a Phase I/II trial in 20 patients who w...